Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $235.99 | 3 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Flexion Therapeutics, Inc. | $182.11 | 1 | $0 (2019) |
| CyMedica Orthopedics, Inc. | $30.00 | 1 | $0 (2018) |
| GlaxoSmithKline, LLC. | $23.88 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2019 | $182.11 | 1 | Flexion Therapeutics, Inc. ($182.11) |
| 2018 | $30.00 | 1 | CyMedica Orthopedics, Inc. ($30.00) |
| 2017 | $23.88 | 1 | GlaxoSmithKline, LLC. ($23.88) |
All Payment Transactions
3 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 04/14/2019 | Flexion Therapeutics, Inc. | Zilretta (Drug) | Food and Beverage | Cash or cash equivalent | $182.11 | General |
| Category: Musculoskeletal | ||||||
| 02/08/2018 | CyMedica Orthopedics, Inc. | — | Food and Beverage | Cash or cash equivalent | $30.00 | General |
| 02/15/2017 | GlaxoSmithKline, LLC. | MENVEO (Biological), BOOSTRIX | Food and Beverage | In-kind items and services | $23.88 | General |
| Category: VACCINES | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 18 | 1,219 | 6,416 | $1.2M | $195,780 |
| 2022 | 17 | 1,220 | 2,834 | $1.0M | $192,135 |
| 2021 | 21 | 1,250 | 2,889 | $877,161 | $197,178 |
| 2020 | 17 | 918 | 2,122 | $622,997 | $118,181 |
All Medicare Procedures & Services
73 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 197 | 315 | $246,507 | $34,434 | 14.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 190 | 190 | $200,342 | $27,520 | 13.7% |
| J7327 | Hyaluronan or derivative, monovisc, for intra-articular injection, per dose | Office | 2023 | 19 | 44 | $127,248 | $24,734 | 19.4% |
| J3304 | Injection, triamcinolone acetonide, preservative-free, extended-release, microsphere formulation, 1 mg | Office | 2023 | 28 | 1,701 | $96,957 | $22,706 | 23.4% |
| 20610 | Aspiration and/or injection of fluid from large joint | Office | 2023 | 151 | 246 | $142,914 | $17,197 | 12.0% |
| J7318 | Hyaluronan or derivative, durolane, for intra-articular injection, 1 mg | Office | 2023 | 30 | 3,061 | $70,599 | $15,470 | 21.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 96 | 137 | $76,478 | $10,754 | 14.1% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 104 | 104 | $74,624 | $10,109 | 13.5% |
| J7326 | Hyaluronan or derivative, gel-one, for intra-articular injection, per dose | Office | 2023 | 13 | 23 | $42,274 | $9,350 | 22.1% |
| 20611 | Aspiration and/or injection of fluid large joint using ultrasound guidance | Office | 2023 | 63 | 86 | $58,415 | $8,973 | 15.4% |
| J7323 | Hyaluronan or derivative, euflexxa, for intra-articular injection, per dose | Office | 2023 | 11 | 48 | $22,704 | $4,860 | 21.4% |
| 73562 | X-ray of knee, 3 views | Office | 2023 | 58 | 67 | $15,756 | $2,773 | 17.6% |
| 73030 | X-ray of shoulder, minimum of 2 views | Office | 2023 | 35 | 44 | $10,238 | $1,579 | 15.4% |
| 20604 | Aspiration and/or injection of fluid from small joint using ultrasound guidance | Office | 2023 | 12 | 17 | $9,232 | $1,463 | 15.8% |
| J1030 | Injection, methylprednisolone acetate, 40 mg | Office | 2023 | 153 | 236 | $5,900 | $1,411 | 23.9% |
| 72100 | X-ray of lower and sacral spine, 2-3 views | Office | 2023 | 30 | 30 | $7,314 | $1,159 | 15.8% |
| 20553 | Injection of trigger points, 3 or more muscles | Office | 2023 | 14 | 19 | $6,432 | $1,043 | 16.2% |
| J0702 | Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg | Office | 2023 | 15 | 48 | $1,104 | $245.16 | 22.2% |
| J7327 | Hyaluronan or derivative, monovisc, for intra-articular injection, per dose | Office | 2022 | 37 | 70 | $202,440 | $42,591 | 21.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 201 | 315 | $217,035 | $36,447 | 16.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 176 | 176 | $161,392 | $26,739 | 16.6% |
| 20610 | Aspiration and/or injection of fluid from large joint | Office | 2022 | 164 | 258 | $127,125 | $18,375 | 14.5% |
| J3304 | Injection, triamcinolone acetonide, preservative-free, extended-release, microsphere formulation, 1 mg | Office | 2022 | 23 | 1,206 | $68,742 | $16,317 | 23.7% |
| J7326 | Hyaluronan or derivative, gel-one, for intra-articular injection, per dose | Office | 2022 | 18 | 31 | $56,978 | $15,421 | 27.1% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 105 | 105 | $65,038 | $10,424 | 16.0% |
About Russell Camhi, DO, ATC
Russell Camhi, DO, ATC is a Sports Medicine healthcare provider based in Great Neck, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/21/2006. The National Provider Identifier (NPI) number assigned to this provider is 1649245911.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Russell Camhi, DO, ATC has received a total of $235.99 in payments from pharmaceutical and medical device companies, with $182.11 received in 2019. These payments were reported across 3 transactions from 3 companies. The most common payment nature is "Food and Beverage" ($235.99).
As a Medicare-enrolled provider, Camhi has provided services to 4,607 Medicare beneficiaries, totaling 14,261 services with total Medicare billing of $703,274. Data is available for 4 years (2020–2023), covering 73 distinct procedure/service records.
Practice Information
- Specialty Sports Medicine
- Location Great Neck, NY
- Active Since 02/21/2006
- Last Updated 08/04/2016
- Taxonomy Code 207QS0010X
- Entity Type Individual
- NPI Number 1649245911
Products in Payments
- Zilretta (Drug) $182.11
- MENVEO (Biological) $23.88
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.